Positives

• Policosanol could be of interest to patients exploring circulation, endothelial dysfunction, lipid changes, or microvascular theories in Long COVID, though the relevance is indirect rather than proven (Examine.com).
• Some older studies reported lipid improvements, which may matter for patients whose chronic illness picture includes cardiometabolic risk, but this does not mean symptom relief is likely (Redalyc).

Negatives

• Independent trial results have been much less impressive, including a JAMA trial that did not find meaningful lipid benefit (JAMA).
• Policosanol is not established as a treatment for brain fog, PEM, dysautonomia, MCAS, Lyme, or chronic fatigue (Examine.com).

Hurdles & Side Effects

• Patients should be careful about combining it with anticoagulants, antiplatelet medications, or other circulation-focused supplements without clinician input (WebMD).
• Because benefits are uncertain, it may be a lower-priority experiment than treatments that target a patient’s clearest symptom pattern (Examine.com).